Sort
82,697 grants matching “vaccine development”
Respiratory Pathogens Reference Laboratory
$850,210University Of Alabama At Birmingham · N01 · FY2010 · AI
Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection
$850,126Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$850,000Pamela J Bjorkman · California Institute Of Technology · P01 · FY2024 · AI
Growth Control in Multiple Myeloma
$849,984Bart Barlogie · Univ Of Arkansas For Med Scis · P01 · FY2009 · CA
Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose
$849,872Bryce C Chackerian · University Of New Mexico Health Scis Ctr · UH3 · FY2025 · DA
Developing Durable, Env-Boosted CAR T Cells for HIV Cure
$849,858Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Gene-Environment Interactions in an Autism Birth Cohort
$849,819W. Ian Lipkin · Columbia University Health Sciences · U01 · FY2010 · NS
Digitally Inoculating Viewers Against Visual Misinformation With a Perceptual Training
$849,761Xiaojin Zhu · University Of Wisconsin-Madison · · FY2022 · CSE
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactions
$849,692Geert-Jan Boons · University Of Georgia · R01 · FY2025 · AI
Integrated genomics research in parasitic tropical diseases
$849,665Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2016 · AI
Human Antibodies and Targeted Vaccines Against SARS-CoV
$849,651Dana-Farber Cancer Institute · U01 · FY2004 · AI
Control Systems Governing Short vs Longterm Humoral & Cellular Immunity
$849,631Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2012 · AI
Task A63: Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus
$849,562David Beasley · University Of Texas Med Br Galveston · N01 · FY2024 · AI
Immune Control and Evasion during Acute HCV Infection
$849,555Bruce D Walker · Massachusetts General Hospital · U19 · FY2006 · AI
Influenza pathogenesis in pregnancy
$849,396Kristina M Adams Waldorf · University Of Washington · R01 · FY2022 · AI
Cervical, Anal, and Oral HPV Persistence and Risk Factors Among Adolescent Girls
$849,386Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · AI
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
$849,367Joel D. Ernst · University Of California, San Francisco · R01 · FY2024 · AI
Optimization of SOSIP Nanoparticle and mRNA Immunogens to Elicit V3 Glycan bNAbs in Rhesus Macaques
$849,354Mark Lewis · Bioqual, Inc. · N01 · FY2024 · AI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
$849,319Stephen Philip Schoenberger · La Jolla Institute For Immunology · U01 · FY2021 · DE
Clinical Development of Combination Plague/Smallpox Vaccine
$849,278Charalambos Partidos · Inviragen, Inc. · R44 · FY2011 · AI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$849,274Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Targeting PD-1 Pathway for Functional Cure of AIDS
$849,204Rama Rao Amara · Emory University · R37 · FY2021 · AI
Project 3 - USUHS
$849,192Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Mechanisms of SIV persistence
$849,076James Burton Whitney · Beth Israel Deaconess Medical Center · R56 · FY2011 · AI
Design of native-like SOSIP trimers
$849,067John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2018 · AI